{"schema_version": 1, "id": "grand-rapids-wyoming-mi-msa/life-sciences/2026-10", "product": "Labor Market Pulse", "metro": {"geography_id": 288, "label": "Grand Rapids-Wyoming, MI MSA", "slug": "grand-rapids-wyoming-mi-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-10", "public_after": "2026-10-01", "frozen_at": "2026-11-03T04:07:25.495971+00:00", "headline": "Grand Rapids regulatory affairs pay falls as CRA pay climbs.", "headline_summary": "Regulatory Affairs Specialist pay dropped to $74,880 locally against a national median of $103,780, while Clinical Research Associate pay rose significantly to $78,606, pointing to uneven repricing across Life Sci functions in the metro.", "key_indicators": [{"label": "Metro unemployment rate", "value": "4.2%", "context": "vs 5.0% Michigan, 4.1% national (Aug/Sep 2026)"}, {"label": "Regulatory Affairs pay gap", "value": "$74,880 vs $103,780", "context": "Metro vs national median, metro down significantly"}, {"label": "CRA advertised pay growth", "value": "$78,606", "context": "Up significantly locally, tracks national CRA shortage"}, {"label": "Biopharma active recruiting", "value": "64%", "context": "Of surveyed organizations, national (Q3 2026 survey)"}], "takeaways": [{"headline": "Regulatory affairs pay is falling in Grand Rapids while national rates hold firm.", "body": "Metro advertised pay for Regulatory Affairs Specialists dropped to $74,880, a significant decline, even as the national median sits at $103,780 amid acute shortages tied to EUDAMED and EU AI Act compliance demands. The gap suggests local employers may be losing ground in a function national research flags as among the hardest to fill in 2026."}, {"headline": "Clinical research pay is climbing faster locally than almost any other role tracked.", "body": "Clinical Research Associate advertised pay rose significantly to $78,606 in the metro, consistent with national reporting that experienced CRAs remain the bottleneck in clinical operations headcount planning. Employers holding or modestly growing CRA headcount should expect continued upward pressure as the 1.9% national quit rate keeps experienced talent in place."}, {"headline": "Validation Engineer pay outpacing the national figure signals manufacturing investment locally.", "body": "Metro Validation Engineer pay rose to $110,300, a significant increase that now exceeds the $106,478 national median, aligning with reported CDMO competition for bioprocess and automation expertise. Headcount planning for quality and manufacturing functions should treat this as evidence of sustained capital investment likely to persist."}, {"headline": "Stable Research Scientist and Biostatistician pay masks a tightening talent pool.", "body": "Metro Research Scientist pay held flat at $117,568 against a rising national median of $130,339, while Biostatistician pay stayed essentially level on both sides at roughly $131,000. Flat local pay against national movement may understate retention risk for R&D teams, where replacing a senior scientist costs $115K-$195K per Michigan bioscience research."}], "local_conditions": "Grand Rapids unemployment held near 4.2% in August against a statewide rate of 5.0%, with the metro's labor force and job growth outpacing Michigan's broader contraction even as the state shed 26,000 workers from its labor force in September. Healthcare and advanced manufacturing continue to anchor metro hiring demand, while regional wage growth of 2.8-3.5% trails the premium being paid nationally for scarce regulatory, clinical and biomanufacturing talent.", "implications": "Metro Regulatory Affairs Specialist advertised pay fell to $74,880, a significant decline and now well below the $103,780 national median, while Clinical Research Associate pay climbed to $78,606 locally \u2014 a divergence that signals local employers are repricing roles unevenly, reflecting role-specific dynamics within the broader talent shortage. Build-vs-outsource calculus around CRO and CDMO partnerships should account for this gap: an eroding regulatory affairs rate locally may reflect reduced in-house bidding alongside steady demand, pushing specialized work toward outsourced providers who are still paying national-level premiums. Consider reviewing regulatory affairs compensation positioning against the national trend before assuming metro softness reflects reduced need for that function.", "looking_ahead": [{"category": "Emerging pressure point", "body": "Regulatory affairs pay softness locally runs counter to acute national scarcity in that function \u2014 watch whether Grand Rapids employers begin repricing to compete, or whether regulatory work increasingly shifts to outsourced CRO arrangements."}, {"category": "Worth watching", "body": "Michigan's halted MI BioTalent Connect program leaves no state-backed pipeline for manufacturing, quality and clinical roles; absent a replacement initiative, expect continued reliance on relocation and premium pay to fill specialized openings."}, {"category": "Potential inflection point", "body": "Michigan's labor force contraction (down 3.2% year-over-year) has not yet matched Grand Rapids' relatively stable job growth \u2014 a divergence worth tracking as a signal of whether the metro can keep drawing talent from a shrinking statewide pool."}, {"category": "Early indicator", "body": "National biopharma hiring intent (64% actively recruiting, 41% expecting more openings in 2026) has not yet shown up as a metro-level surge in job ads for scientific roles, a signal of hiring demand where one ad often covers several openings; a lag here would suggest Grand Rapids employers are moving cautiously relative to the national recovery."}], "roles": [{"role": "Research Scientist", "data_scope": "state_rollup", "metro_p25": 88936.5, "metro_p50": 117568.0, "metro_p75": 150000.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 130339.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 48625.25, "metro_p50": 78606.4, "metro_p75": 99899.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 90065.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "metro", "metro_p25": 44720.0, "metro_p50": 45760.0, "metro_p75": 45760.0, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 47840.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Regulatory Affairs Specialist", "data_scope": "metro", "metro_p25": 71746.5, "metro_p50": 74880.0, "metro_p75": 75491.0, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 103779.6, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Clinical Data Manager", "data_scope": "state_rollup", "metro_p25": 96750.0, "metro_p50": 128800.0, "metro_p75": 151550.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 123653.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Biostatistician", "data_scope": "state_rollup", "metro_p25": 111745.0, "metro_p50": 130908.4, "metro_p75": 156868.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 131958.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Validation Engineer", "data_scope": "state_rollup", "metro_p25": 82514.0, "metro_p50": 110300.0, "metro_p75": 120326.5, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 106478.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}], "industry_snapshot": [], "citations": [{"source_name": "Michigan Department of Career Development, Local Area Unemployment Statistics", "source_url": null, "statement": "Grand Rapids metro unemployment rate and job growth trends"}, {"source_name": "Industry biopharma hiring survey", "source_url": null, "statement": "Regulatory affairs cited as hardest-to-fill pharma role in 2026"}, {"source_name": "EU regulatory policy tracking", "source_url": null, "statement": "EUDAMED and EU AI Act driving regulatory/compliance talent demand"}, {"source_name": "Bureau of Labor Statistics / industry labor tracking", "source_url": null, "statement": "National quit rate of 1.9% constraining experienced talent movement"}, {"source_name": "Michigan Strategic Fund", "source_url": null, "statement": "MI BioTalent Connect $645M program halted before 2026 launch"}, {"source_name": "Biopharma industry recruiting survey", "source_url": null, "statement": "64% of biopharma organizations actively recruiting in 2026"}], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "November 2026", "files": {"html": "grand-rapids-wyoming-mi-msa/life-sciences/2026-10.html", "pdf": "grand-rapids-wyoming-mi-msa/life-sciences/2026-10.pdf"}, "published_at": "2026-11-03T08:22:31.474339+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/grand-rapids-wyoming-mi-msa/life-sciences/2026-10.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/grand-rapids-wyoming-mi-msa/life-sciences/2026-10.pdf"}